Here's Why Bristol Myers Squibb Is Making A Mistake With Its Cash

Bristol Myers Squibb (NYSE: BMY) is generating plenty of cash flow and recently used $4 billion of its nest egg to pay down debt. In this video from Motley Fool Live recorded on Feb. 8 (before the transaction was completed), Fool.com contributors Brian Orelli and Keith Speights discuss why that might not be the best use of the pharma company's cash. Brian Orelli: The company plans to retire $4 billion in debt.